Pro/con clinical debate: is high-frequency oscillatory ventilation useful in the management of adult patients with respiratory failure?
In neonatal and pediatric intensive care units, high-frequency oscillatory ventilation (HFOV) has become an increasingly common therapy. This may not have been the case if researchers had not persisted in investigating the therapy after early disappointing clinical trials. Devices capable of providing this therapy to adults have become commercially available relatively recently. However, there are many questions that need to be answered regarding HFOV in adults: Is HFOV in adults superior to conventional mechanical ventilation? Who is the ideal candidate for HFOV? When should it be applied? What is the best technique with which to apply it? When should a patient on HFOV be converted back to conventional ventilation? What is the safety and efficacy of the device? As outlined in the following debate, there are several compelling arguments for and against the use of HFOV at this point in adults.
Department of Medicine, Mount Sinai Hospital, Toronto, Canada.
Jeffrey M
JM
Singh
Sangeeta
S
Mehta
Robert M
RM
Kacmarek
D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006612:High-Frequency Ventilation / Q000379:methods*; D006801:Humans; D010100:Oxygen / Q000378:metabolism; D011659:Pulmonary Gas Exchange; D012128:Respiratory Distress Syndrome / Q000628:therapy*; D012131:Respiratory Insufficiency / Q000628:therapy*
D010100:Oxygen